BPA Call 36E79720A0008-36C24122N0162
Award Date
12/7/21
Potential Completion Date
12/6/22
Potential Value
$366K
Federal Agency
Veterans Integrated Service Network 1
Awardee
United Therapeutics Corp
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Veterans Affairs (VA) awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods, for the supply of Tyvaso 0.6mg/mL Refill Kits. The $127,989.18 award is placed against United Therapeutics' $50 million BPA contract with the VA National Acquisition Center for the company's portfolio of pulmonary arterial hypertension and oncology drugs, including...
This is a firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corporation, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The contract, valued at $32,063.20, is for the supply of Tyvaso (treprostinil) inhalation solution, a medication used to treat pulmonary arterial hypertension. The contract was awarded under United Therapeutics' Federal Supply Schedule (FSS) contract for...
This is a firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The contract is for the supply of Tyvaso (treprostinil) inhalation solution, a medication used to treat pulmonary arterial hypertension. The contract, valued at $16,391.56, was awarded on February 15, 2024 and has a period of performance ending on January 31, 2025. It was...
This federal contract award is for the delivery of the drug Tyvaso to the U.S. Department of Veterans Affairs (VA). The prime contractor is United Therapeutics Corp, a self-certified small disadvantaged business and for-profit manufacturer of pharmaceutical goods. The contract has a ceiling value of $151,408.29 and is a firm-fixed-price delivery order placed against United Therapeutics' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs. The contract supports the VA's mission...
This federal contract award is for the procurement of TYVASO, a pharmaceutical product developed and manufactured by United Therapeutics Corp, a self-certified small disadvantaged business. The contract, worth $13,050.45, was awarded by the Veterans Integrated Service Network 1 (VISN 1), a division of the U.S. Department of Veterans Affairs (VA), to United Therapeutics as the prime contractor. This is a firm fixed-price Blanket Purchase Agreement (BPA) call order placed against United...
This federal contract award is for the supply of Tyvaso (treprostinil) inhalation solution to the U.S. Department of Veterans Affairs (VA). The $186,978.50 firm-fixed-price contract was awarded to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The contract is a Blanket Purchase Agreement (BPA) call order under United Therapeutics' $50 million BPA with the VA National Acquisition Center, which enables the VA to efficiently procure...
This federal contract award was made by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corporation, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The $14,989.01 firm-fixed-price delivery order is for Tyvaso 0.6 Refill Kits, which are used to treat pulmonary arterial hypertension. This order falls under United Therapeutics' Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs with the VA. The company also holds a $50...
This federal contract award is for TYVASO TREPROSTINIL, a pharmaceutical product, awarded to United Therapeutics Corp, a registered small disadvantaged business and manufacturer of pharmaceutical goods. The $31,959.14 firm fixed price delivery order is placed against United Therapeutics' Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs (VA) for Pharmaceuticals and Drugs. Additionally, United Therapeutics holds a $50 million VA Blanket Purchase Agreement (BPA) and...
This is a firm-fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to United Therapeutics Corp, a self-certified small disadvantaged business and manufacturer of pharmaceutical goods. The $88,161.72 order is for Tyvaso (treprostinil) inhalation solution, a drug used to treat pulmonary arterial hypertension. The delivery order was placed against United Therapeutics' $198 million Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs, which allows the...
This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) to United Therapeutics Corp, a manufacturer of pharmaceutical goods. The contract, valued at $14,693.62, is for the supply of Tyvaso inhalation solution and related products to the VA's Veterans Integrated Service Network 21. United Therapeutics holds two national indefinite delivery/indefinite quantity (IDIQ) contracts with the VA, one valued at $50 million and the other at $198 million, which provide a...